Pluri (PLUR) Operating Margin (2011 - 2025)
Pluri (PLUR) posted quarterly Operating Margin of 3285.86% for Q4 2025, down 60640.0% year-over-year from N/an in Q4 2024, and down 63.52% quarter-over-quarter from 2009.49% in Q3 2025.
Pluri (PLUR) Operating Margin (2011 - 2025) Analysis & Trends
Pluri (PLUR) has reported Operating Margin for 12 consecutive years, with 3285.86% the latest figure, recorded in Q4 2025.
- In Q4 2025, Operating Margin fell 60640.0% year-over-year to 3285.86%; the TTM figure through Dec 2025 stood at 1857.88% (up 134610.0% YoY), while the FY2025 annual figure was 1659.88%, up 513705.0% from the prior year.
- Operating Margin retreated to 3285.86% in Q4 2025 per PLUR's latest filing, from 2009.49% in the prior quarter.
- Across five years, Operating Margin topped out at 1264.64% in Q1 2025 and bottomed at 333950.0% in Q4 2022.
- Historically, Operating Margin has averaged 26795.99% across 4 years, with a median of 4964.76% in 2023.
- On a YoY basis, Operating Margin climbed as much as 32898524 bps in 2023 and fell as far as 368442 bps in 2023.
- Pluri's Operating Margin stood at 333950.0% in 2022, then soared by 99 bps to 4964.76% in 2023, then surged by 46 bps to 2679.46% in 2024, then fell by 23 bps to 3285.86% in 2025.
- Business Quant data shows PLUR's Operating Margin at 3285.86% in Q4 2025, 2009.49% in Q3 2025, and 1663.57% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.64 Bn | 130.78 Bn | 2.84 Bn | 37.40% |
| 2 | Regeneron Pharmaceuticals | 85.89 Bn | 77.90 Bn | 3.93 Bn | 30.15% |
| 3 | Argenx Se | 65.11 Bn | 59.93 Bn | 1.37 Bn | 32.54% |
| 4 | Moderna | 55.83 Bn | 50.69 Bn | 52.00 Mn | -562.07% |
| 5 | BeOne Medicines | 42.01 Bn | 36.91 Bn | 1.53 Bn | 19.06% |
| 6 | Alnylam Pharmaceuticals | 31.63 Bn | 28.32 Bn | 992.69 Mn | 17.93% |
| 7 | BioNTech SE | 27.65 Bn | 9.26 Bn | 668.28 Mn | -35.57% |
| 8 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn | -0.36% |
| 9 | Royalty Pharma | 27.30 Bn | 26.47 Bn | - | 19.75% |
| 10 | Pluri | 16.02 Mn | 3.54 Mn | 86,000.00 | -3,285.86% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -3,285.86% |
| Sep 30, 2025 | -2,009.49% |
| Jun 30, 2025 | -1,663.57% |
| Mar 31, 2025 | -1,264.64% |
| Dec 31, 2024 | -2,679.46% |
| Sep 30, 2024 | -1,594.48% |
| Jun 30, 2024 | -6,285.42% |
| Mar 31, 2024 | -7,794.37% |
| Dec 31, 2023 | -4,964.76% |
| Sep 30, 2023 | -9,957.41% |
| Jun 30, 2023 | -5,895.50% |
| Mar 31, 2023 | -8,160.92% |
| Dec 31, 2022 | -333,950.00% |
| Sep 30, 2022 | -7,957.47% |
| Mar 31, 2022 | -4,476.50% |
| Dec 31, 2019 | -27,686.96% |
| Dec 31, 2018 | -16,662.00% |
| Sep 30, 2018 | -224,250.00% |
| Dec 31, 2017 | -16,934.00% |
| Dec 31, 2015 | -153.63% |